Bluetongue vaccines in Europe.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Polish journal of veterinary sciences

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.2478/V10181-011-0048-1PMID 21721420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Bluetongue Virus Serotype from Kuwait

  2011cited by this paper
• Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.

  2010cited by this paper
• Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.

  2009cited by this paper
• Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle

  2009cited by this paper
• The pathology and pathogenesis of bluetongue.

  2009cited by this paper
• Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

  2009cited by this paper
• Emergence of bluetongue serotypes in Europe, part 2: the occurrence of a BTV-11 strain in Belgium.

  2009cited by this paper
• Prospects for improved bluetongue vaccines

  2009cited by this paper
• Bluetongue in Europe: past, present and future

  2009influential reference
• Bluetongue vaccines.

  2009cited by this paper
• Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.

  2009cited by this paper
• Exotic Disease of Farm Animals Tests Europe's Responses

  2008cited by this paper
• Vaccines against bluetongue in Europe.

  2008influential reference
• A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

  2008cited by this paper
• Bluetongue virus: virology, pathogenesis and immunity.

  2008cited by this paper
• Orbiviruses in the Mediterranean basin: updated epidemiological situation of Bluetongue and new methods for the detection of BTV serotype 4.

  2008cited by this paper
• Evidence for transplacental and contact transmission of bluetongue virus in cattle

  2008cited by this paper
• Genetic Characterization of Toggenburg Orbivirus, a New Bluetongue Virus, from Goats, Switzerland

  2008cited by this paper
• Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants.

  2007cited by this paper
• An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.

  2007cited by this paper
• Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.

  2007cited by this paper
• Recovery of Infectious Bluetongue Virus from RNA

  2006cited by this paper
• Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.

  2006cited by this paper
• Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2.

  2004influential reference
• Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.

  2004influential reference
• Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.

  2004cited by this paper
• The history of bluetongue and a current global overview.

  2004cited by this paper
• Bluetongue vaccination in Europe: the Italian experience.

  2004cited by this paper
• The history of bluetongue and a current global overview.

  2004cited by this paper
• Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.

  2004influential reference
• Bluetongue virus in the Mediterranean Basin 1998-2001.

  2002cited by this paper
• Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

  1997cited by this paper
• The pathogenesis and immunology of bluetongue virus infection of ruminants.

  1994influential reference
• Protective efficacy of virus-like particles for bluetongue disease.

  1992influential reference
• Bluetongue Viruses

  1990cited by this paper
• Recombinant virus vaccine for bluetongue disease in sheep

  1990cited by this paper

• Perspective vaccines for emerging viral diseases in farm animals

  2023cites this paper
• History and Promise of Plant-Made Vaccines for Animals

  2018cites this paper
• Some adverse events following immunization in veterinary medicine

  2018cites this paper
• New generation vaccines against bluetongue virus

  2018cites this paper
• Development of plant-produced protein body vaccine candidates for bluetongue virus

  2017cites this paper
• Innocuity of a commercial live attenuated vaccine for epizootic hemorrhagic disease virus serotype 2 in late-term pregnant cows.

  2016cites this paper
• PCR- RFLP for Identification of Bluetongue Virus Serotypes

  2015cites this paper
• Viral Hemorrhagic Fevers of Animals Caused by Double-Stranded RNA Viruses

  2015cites this paper
• Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue.

  2015cites this paper
• Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.

  2014cites this paper
• Development of plant-produced Bluetongue virus vaccines

  2014influential citation
• Public Health and Vector‐Borne Diseases – A New Concept for Risk Governance

  2013cites this paper
• Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.

  2013cites this paper
• Virus-like particle-based vaccines for animal viral infections

  2012cites this paper
• Virus-like particles: The new frontier of vaccines for animal viral infections

  2012cites this paper
• Evaluation of inhibitory effect of shRNA constructs in bluetongue virus (BTV) Replication

  2012cites this paper
• IMMUNOGENIC PROPERTIES OF CALICIVIRUS-LIKE PARTICLES AS VACCINE VECTORS

  2011cites this paper